Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes.
暂无分享,去创建一个
P. De Baetselier | M. Mack | D. Pipeleers | C. Gysemans | K. Movahedi | J. V. Van Ginderachter | P. in’t Veld | D. Laoui | G. Stangé | M. Baeten | J. Van den Bossche | J. van den Bossche | Damya Laoui
[1] A. Sica,et al. A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships. , 2009, Blood.
[2] P. Sinha,et al. Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer 1 , 2009, The Journal of Immunology.
[3] F. Geissmann,et al. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. , 2009, Annual review of immunology.
[4] S. Gordon,et al. Alternative activation of macrophages: an immunologic functional perspective. , 2009, Annual review of immunology.
[5] D. Hume,et al. CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their response to inflammation , 2009, The Journal of experimental medicine.
[6] William King,et al. High-density gene expression analysis of tumor-associated macrophages from mouse mammary tumors. , 2009, The American journal of pathology.
[7] Srinivas Nagaraj,et al. Myeloid-derived suppressor cells as regulators of the immune system , 2009, Nature Reviews Immunology.
[8] T. Kakiuchi,et al. Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute TH1 immune responses , 2009, Nature Immunology.
[9] P. De Baetselier,et al. IL-10 Dampens TNF/Inducible Nitric Oxide Synthase-Producing Dendritic Cell-Mediated Pathogenicity during Parasitic Infection1 , 2009, The Journal of Immunology.
[10] Steffen Jung,et al. Origins and tissue‐context‐dependent fates of blood monocytes , 2009, Immunology and cell biology.
[11] A. Sica,et al. Divergent effects of hypoxia on dendritic cell functions. , 2008, Blood.
[12] Michelle Collazo,et al. Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice1 , 2008, The Journal of Immunology.
[13] P. Allavena,et al. Cancer-related inflammation , 2008, Nature.
[14] J. Talmadge,et al. Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice. , 2008, Blood.
[15] T. Lawrence,et al. “Re-educating” tumor-associated macrophages by targeting NF-κB , 2008, The Journal of experimental medicine.
[16] M. Karin,et al. An antiinflammatory role for IKKβ through the inhibition of “classical” macrophage activation , 2008, The Journal of experimental medicine.
[17] Katerina Akassoglou,et al. NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α , 2008, Nature.
[18] C. Mathieu,et al. Pancreatic Duct Cells in Human Islet Cell Preparations Are a Source of Angiogenic Cytokines Interleukin-8 and Vascular Endothelial Growth Factor , 2008, Diabetes.
[19] Henk C. Hoogsteden,et al. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells , 2008, The Journal of experimental medicine.
[20] Craig Murdoch,et al. Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response. , 2008, Neoplasia.
[21] P. De Baetselier,et al. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. , 2008, Blood.
[22] L. Naldini,et al. Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications. , 2007, Trends in immunology.
[23] Clare L. Bennett,et al. DC ablation in mice: promises, pitfalls, and challenges. , 2007, Trends in immunology.
[24] A. Cumano,et al. Monitoring of Blood Vessels and Tissues by a Population of Monocytes with Patrolling Behavior , 2007, Science.
[25] T. Suda,et al. Angiogenic Role of LYVE-1–Positive Macrophages in Adipose Tissue , 2007, Circulation research.
[26] F. Tacke,et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. , 2007, The Journal of clinical investigation.
[27] J. Pollard,et al. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. , 2006, Cancer research.
[28] L. Brys,et al. Peroxisome proliferator-activated receptor γ (PPARγ) ligands reverse CTL suppression by alternatively activated (M2) macrophages in cancer , 2006 .
[29] S. Gordon,et al. Ovarian Cancer Cells Polarize Macrophages Toward A Tumor-Associated Phenotype1 , 2006, The Journal of Immunology.
[30] Alberto Mantovani,et al. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. , 2006, European journal of cancer.
[31] F. Ginhoux,et al. Immature monocytes acquire antigens from other cells in the bone marrow and present them to T cells after maturing in the periphery , 2006, The Journal of experimental medicine.
[32] A. Sica,et al. A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). , 2006, Blood.
[33] E. Pamer,et al. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2 , 2006, Nature Immunology.
[34] J. Pollard,et al. Distinct role of macrophages in different tumor microenvironments. , 2006, Cancer research.
[35] C. Reis e Sousa. Dendritic cells in a mature age , 2006, Nature reviews. Immunology.
[36] M. Burdick,et al. CXC chemokines in angiogenesis , 2000, Journal of leukocyte biology.
[37] C. Lewis,et al. Hypoxia Regulates Macrophage Functions in Inflammation1 , 2005, The Journal of Immunology.
[38] C. Lewis,et al. Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies. , 2005, The American journal of pathology.
[39] Silvano Sozzani,et al. The chemokine system in diverse forms of macrophage activation and polarization. , 2004, Trends in immunology.
[40] P. Lollini,et al. TS/A: a new metastasizing cell line from a BALB/c spontaneous mammary adenocarcinoma , 1983, Clinical & Experimental Metastasis.
[41] J. Pollard. Tumour-educated macrophages promote tumour progression and metastasis , 2004, Nature Reviews Cancer.
[42] M. Simon,et al. Expansion of human SCID-repopulating cells under hypoxic conditions. , 2003, The Journal of clinical investigation.
[43] P. Ratcliffe,et al. Regulation of angiogenesis by hypoxia: role of the HIF system , 2003, Nature Medicine.
[44] P. De Baetselier,et al. Nitric Oxide-Independent CTL Suppression during Tumor Progression: Association with Arginase-Producing (M2) Myeloid Cells1 , 2003, The Journal of Immunology.
[45] S. Ostrand-Rosenberg,et al. Mouse 4T1 Breast Tumor Model , 2000, Current protocols in immunology.
[46] Johannes Gerdes,et al. The Ki‐67 protein: From the known and the unknown , 2000, Journal of cellular physiology.
[47] N. Van Rooijen,et al. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. , 1994, Journal of immunological methods.
[48] P. De Baetselier,et al. Characterization of 3ll‐tumor variants generated by in vitro macrophage‐mediated selection , 1987, International journal of cancer.